Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02142829 · ClinicalTrials.gov registry record · Phase 4

Pain Control in Bariatric Patients: EXPAREL(R) vs. the On-Q(R) Pain Ball

A Phase 4 study of Obesity, sponsored by Pacira Pharmaceuticals.

Completed
Registry status
Phase 4
Development phase
101
Enrollment target
1
Study location

NCT02142829: Completed Phase 4 study of Obesity, sponsored by Pacira Pharmaceuticals.

NCT02142829 is a Phase 4 study of Obesity that has completed, run by Pacira Pharmaceuticals. The registered enrollment target is 101 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02142829, a Phase 4 study of Obesity, has completed, sponsored by Pacira Pharmaceuticals.

COMPLETED
Registry status
Phase 4
Development phase
101 participants
Enrollment target
1
Study location

Study Summary

This study was conducted to compare the effectiveness of two local pain control methods in bariatric patients by assessing the amount of postoperative pain and amount of postoperative pain medications needed. This information was used to determine which local anesthetic provided the best pain control.

Conditions Studied

Interventions

  • DRUG EXPAREL
  • DRUG On-Q Pain Ball

Study Locations (1)

Texas

  • Bariatric Medical Institute of Texas - San Antonio

Trial Details

FieldValue
Enrollment Target 101 participants
Start Date 2012-11
Est. Completion 2013-03
Phase Phase 4

Sponsor

Pacira Pharmaceuticals

88 total trials

What the Registry Record Tells You About NCT02142829

The ClinicalTrials.gov registry entry for NCT02142829 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (88% lower). The listed sponsor is Pacira Pharmaceuticals, which has 88 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which EXPAREL is the first listed.

NCT02142829 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT02142829 about?

NCT02142829 is a clinical study titled "Pain Control in Bariatric Patients: EXPAREL(R) vs. the On-Q(R) Pain Ball". This study was conducted to compare the effectiveness of two local pain control methods in bariatric patients by assessing the amount of postoperative pain and amount of postoperative pain medications needed. This information was used to determine which local anesthetic provided the best pain contro...

What is the current status of trial NCT02142829?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 101 participants. The study started on 2012-11. Estimated completion is 2013-03.

What conditions does trial NCT02142829 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT02142829?

The interventions under investigation include: EXPAREL (DRUG), On-Q Pain Ball (DRUG).

Who is sponsoring clinical trial NCT02142829?

This trial is sponsored by Pacira Pharmaceuticals, which has 88 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02142829 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.